Condition: Esophageal Cancer · Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
The Phase Ib stage of this study primarily aims to evaluate the tolerance and safety of TQB6411 Injection in participants with recurrent or metastatic Esophageal cancer who have previously failed treatment with PD-1/PD-L1 monoclonal antibodies combined with platinum-based chemotherapy. The Phase II stage primarily aims to evaluate the efficacy of TQB6411 Injection in this same participants population.
This description comes directly from the study's public registry record.
Feng Wang, Doctor · 13938244776 · fengw010@163.com
Always discuss trial participation with your own doctor first.
| The Second Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | Not Yet Recruiting |
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Fujian Cancer Hospital | Fuzhou, Fujian, China | Not Yet Recruiting |
| Gansu Provincial Tumor Hospital | Lanzhou, Gansu, China | Not Yet Recruiting |
| The First Affiliated Hospital of Shantou University Medical College | Shantou, Guangdong, China | Not Yet Recruiting |
| Guangxi Medical University Cancer Hospital | Nanning, Guangxi, China | Not Yet Recruiting |
| Guizhou Provincial People's Hospital | Guangxi, Guizhou, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Zunyi Medical University | Zunyi, Guizhou, China | Not Yet Recruiting |
| Harbin Medical University Cancer Hospital | Harbin, Heilongjiang, China | Not Yet Recruiting |
| Anyang Cancer Hospital | Anyang, Henan, China | Not Yet Recruiting |
| The Second People's Hosital of Jiaozuo | Jiaozuo, Henan, China | Not Yet Recruiting |
| Luoyang Central Hospital (Zhengzhou University Affiliated Luoyang Central Hospital) | Luoyang, Henan, China | Not Yet Recruiting |
+ 18 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07367516